Results 151 to 160 of about 3,217 (222)

A phase 1b/2 study of intermittent talazoparib plus temozolomide in patients with metastatic castration-resistant prostate cancer and no mutations in DNA damage response genes. [PDF]

open access: yesInvest New Drugs
Autio KA   +11 more
europepmc   +1 more source

Discovery of the most compact 3+1-type quadruple star system TIC 120362137. [PDF]

open access: yesNat Commun
Borkovits T   +20 more
europepmc   +1 more source

Open educational resources for distributed hands-on teaching in molecular biology. [PDF]

open access: yesPLoS One
Cerda A   +24 more
europepmc   +1 more source

Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancer. [PDF]

open access: yesLung Cancer
Sun F   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy